Add to Watchlist
View Current for INCY
View SuperFeed for INCY
View Charts for INCY
Add or remove $INCY from your watchlists:
Hang tight! We're updating your watchlist data. This might take a minute...
You have not created a stock watchlist.
Create one now to track $INCY!
Done
Manage Watchlists
Incyte Corporation
Health Care
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology…
more
Conversation Volume
Last 60 days
There is not enough conversation volume about this stock
Key Opinion Leaders
Strongest 30-day focus on $INCY by total mentions
Real-time Chart
Price Chart for $INCY
Conviction History
Bullish vs Bearish Conviction over the last 30 days.
This color denotes Market Hours (US/Eastern)
There is not enough conversation volume about this stock
Thread Explorer
Explore popular threads around $INCY
There are no threads for this stock
Chart Explorer
Explore recent charts, graphs, and media
There are no charts for this stock
Rarely do we see this kind of divergence between value ($SPYV = black line) and growth ($SPYG = red line). Check it out this 5 year chart...
Go to Chart Explorer
Latest News
Get the latest breaking news from the community
There is no recent news for this stock
Loading news, hang tight...
Google Search Trends - Past 12 months
Instantly visualize search trends for this specific symbol
Today
Past 7 days
Past 30 days
Past 60 days
Custom
Company Profile
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally. The company offers JAKAFI (ruxolitinib), for the treatment of adults with intermediate or high-risk myelofibrosis; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include axatilimab, an anti-CSF-1R monoclonal antibody being developed as a therapy for patients with chronic GVHD as well as in additional immune-mediated diseases; and parsaclisib, a PI3Kd inhibitor which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. It also develops retifanlimab, is in Phase III clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer, and Fast Track designation for the treatment of metastatic MSI-H or DNA mismatch repair (dMMR) endometrial cancer; and INCB99280 and INCB99318 currently under Phase I for the treatment solid tumors. It has collaboration out- license agreements with Novartis, Lilly, Innovent, InnoCare, Maruho, and CMS Aesthetics Limited; and in- license agreements with Agenus, Merus, MacroGenics, Syros, MorphoSys, and Syndax. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Market Cap Type: Large
Close
Date,Time,Temperature
2024-09-30,11,0
2024-09-30,12,0
2024-09-30,13,0
2024-09-30,14,0
2024-09-30,15,0
2024-09-30,16,0
2024-09-30,17,0
2024-09-30,18,0
2024-09-30,19,0
2024-09-30,20,0
2024-09-30,21,0
2024-09-30,22,0
2024-09-30,23,0
2024-10-01,0,0
2024-10-01,1,0
2024-10-01,2,0
2024-10-01,3,0
2024-10-01,4,0
2024-10-01,5,0
2024-10-01,6,0
2024-10-01,7,0
2024-10-01,8,0
2024-10-01,9,0
2024-10-01,10,0
2024-10-01,11,0
2024-10-01,12,0
2024-10-01,13,0
2024-10-01,14,0
2024-10-01,15,0
2024-10-01,16,0
2024-10-01,17,0
2024-10-01,18,0
2024-10-01,19,0
2024-10-01,20,0
2024-10-01,21,0
2024-10-01,22,0
2024-10-01,23,0
2024-10-02,0,0
2024-10-02,1,0
2024-10-02,2,0
2024-10-02,3,0
2024-10-02,4,0
2024-10-02,5,0
2024-10-02,6,0
2024-10-02,7,0
2024-10-02,8,0
2024-10-02,9,0
2024-10-02,10,0
2024-10-02,11,0
2024-10-02,12,0
2024-10-02,13,0
2024-10-02,14,0
2024-10-02,15,0
2024-10-02,16,0
2024-10-02,17,0
2024-10-02,18,0
2024-10-02,19,0
2024-10-02,20,0
2024-10-02,21,0
2024-10-02,22,0
2024-10-02,23,0
2024-10-03,0,0
2024-10-03,1,0
2024-10-03,2,0
2024-10-03,3,0
2024-10-03,4,0
2024-10-03,5,0
2024-10-03,6,0
2024-10-03,7,0
2024-10-03,8,0
2024-10-03,9,0
2024-10-03,10,0
2024-10-03,11,0
2024-10-03,12,0
2024-10-03,13,0
2024-10-03,14,0
2024-10-03,15,0
2024-10-03,16,0
2024-10-03,17,0
2024-10-03,18,0
2024-10-03,19,0
2024-10-03,20,0
2024-10-03,21,0
2024-10-03,22,0
2024-10-03,23,0
2024-10-04,0,0
2024-10-04,1,0
2024-10-04,2,0
2024-10-04,3,0
2024-10-04,4,0
2024-10-04,5,0
2024-10-04,6,0
2024-10-04,7,0
2024-10-04,8,0
2024-10-04,9,0
2024-10-04,10,0
2024-10-04,11,0
2024-10-04,12,0
2024-10-04,13,0
2024-10-04,14,0
2024-10-04,15,0
2024-10-04,16,0
2024-10-04,17,0
2024-10-04,18,0
2024-10-04,19,0
2024-10-04,20,0
2024-10-04,21,0
2024-10-04,22,0
2024-10-04,23,0
2024-10-05,0,0
2024-10-05,1,0
2024-10-05,2,0
2024-10-05,3,0
2024-10-05,4,0
2024-10-05,5,0
2024-10-05,6,0
2024-10-05,7,0
2024-10-05,8,0
2024-10-05,9,0
2024-10-05,10,0
2024-10-05,11,0
2024-10-05,12,0
2024-10-05,13,0
2024-10-05,14,0
2024-10-05,15,0
2024-10-05,16,0
2024-10-05,17,0
2024-10-05,18,0
2024-10-05,19,0
2024-10-05,20,0
2024-10-05,21,0
2024-10-05,22,0
2024-10-05,23,0
2024-10-06,0,0
2024-10-06,1,0
2024-10-06,2,0
2024-10-06,3,0
2024-10-06,4,0
2024-10-06,5,0
2024-10-06,6,0
2024-10-06,7,0
2024-10-06,8,0
2024-10-06,9,0
2024-10-06,10,0
2024-10-06,11,0
2024-10-06,12,0
2024-10-06,13,0
2024-10-06,14,0
2024-10-06,15,0
2024-10-06,16,0
2024-10-06,17,0
2024-10-06,18,0
2024-10-06,19,0
2024-10-06,20,0
2024-10-06,21,0
2024-10-06,22,0
2024-10-06,23,0
2024-10-07,0,0
2024-10-07,1,0
2024-10-07,2,0
2024-10-07,3,0
2024-10-07,4,0
2024-10-07,5,0
2024-10-07,6,0
2024-10-07,7,0
2024-10-07,8,0
2024-10-07,9,0
2024-10-07,10,0
2024-10-07,11,0
2024-10-07,12,0
2024-10-07,13,0
2024-10-07,14,0
2024-10-07,15,0
2024-10-07,16,0
2024-10-07,17,0
2024-10-07,18,0
2024-10-07,19,0
2024-10-07,20,0
2024-10-07,21,0
2024-10-07,22,0
2024-10-07,23,0
2024-10-08,0,0
2024-10-08,1,0
2024-10-08,2,0
2024-10-08,3,0
2024-10-08,4,0
2024-10-08,5,0
2024-10-08,6,0
2024-10-08,7,0
2024-10-08,8,0
2024-10-08,9,0
2024-10-08,10,0
2024-10-08,11,0
2024-10-08,12,0
2024-10-08,13,0
2024-10-08,14,0
2024-10-08,15,0
2024-10-08,16,0
2024-10-08,17,0
2024-10-08,18,0
2024-10-08,19,0
2024-10-08,20,0
2024-10-08,21,0
2024-10-08,22,0
2024-10-08,23,0
2024-10-09,0,0
2024-10-09,1,0
2024-10-09,2,0
2024-10-09,3,0
2024-10-09,4,0
2024-10-09,5,0
2024-10-09,6,0
2024-10-09,7,0
2024-10-09,8,0
2024-10-09,9,0
2024-10-09,10,0
2024-10-09,11,0
2024-10-09,12,0
2024-10-09,13,0
2024-10-09,14,0
2024-10-09,15,0
2024-10-09,16,0
2024-10-09,17,0
2024-10-09,18,0
2024-10-09,19,0
2024-10-09,20,0
2024-10-09,21,0
2024-10-09,22,0
2024-10-09,23,0
2024-10-10,0,0
2024-10-10,1,0
2024-10-10,2,0
2024-10-10,3,0
2024-10-10,4,0
2024-10-10,5,0
2024-10-10,6,0
2024-10-10,7,0
2024-10-10,8,0
2024-10-10,9,0
2024-10-10,10,0
2024-10-10,11,0
2024-10-10,12,0
2024-10-10,13,0
2024-10-10,14,0
2024-10-10,15,0
2024-10-10,16,0
2024-10-10,17,0
2024-10-10,18,0
2024-10-10,19,0
2024-10-10,20,0
2024-10-10,21,0
2024-10-10,22,0
2024-10-10,23,0
2024-10-11,0,0
2024-10-11,1,0
2024-10-11,2,0
2024-10-11,3,0
2024-10-11,4,0
2024-10-11,5,0
2024-10-11,6,0
2024-10-11,7,0
2024-10-11,8,0
2024-10-11,9,0
2024-10-11,10,0
2024-10-11,11,0
2024-10-11,12,0
2024-10-11,13,0
2024-10-11,14,0
2024-10-11,15,0
2024-10-11,16,0
2024-10-11,17,0
2024-10-11,18,0
2024-10-11,19,0
2024-10-11,20,0
2024-10-11,21,0
2024-10-11,22,0
2024-10-11,23,0
2024-10-12,0,0
2024-10-12,1,0
2024-10-12,2,0
2024-10-12,3,0
2024-10-12,4,0
2024-10-12,5,0
2024-10-12,6,0
2024-10-12,7,0
2024-10-12,8,0
2024-10-12,9,0
2024-10-12,10,0
2024-10-12,11,0
2024-10-12,12,0
2024-10-12,13,0
2024-10-12,14,0
2024-10-12,15,0
2024-10-12,16,0
2024-10-12,17,0
2024-10-12,18,0
2024-10-12,19,0
2024-10-12,20,0
2024-10-12,21,0
2024-10-12,22,0
2024-10-12,23,0
2024-10-13,0,0
2024-10-13,1,0
2024-10-13,2,0
2024-10-13,3,0
2024-10-13,4,0
2024-10-13,5,0
2024-10-13,6,0
2024-10-13,7,0
2024-10-13,8,0
2024-10-13,9,0
2024-10-13,10,0
2024-10-13,11,0
2024-10-13,12,0
2024-10-13,13,0
2024-10-13,14,0
2024-10-13,15,0
2024-10-13,16,0
2024-10-13,17,0
2024-10-13,18,0
2024-10-13,19,0
2024-10-13,20,0
2024-10-13,21,0
2024-10-13,22,0
2024-10-13,23,0
2024-10-14,0,0
2024-10-14,1,0
2024-10-14,2,0
2024-10-14,3,0
2024-10-14,4,0
2024-10-14,5,0
2024-10-14,6,0
2024-10-14,7,0
2024-10-14,8,0
2024-10-14,9,0
2024-10-14,10,0
2024-10-14,11,0
2024-10-14,12,0
2024-10-14,13,0
2024-10-14,14,0
2024-10-14,15,0
2024-10-14,16,0
2024-10-14,17,0
2024-10-14,18,0
2024-10-14,19,0
2024-10-14,20,0
2024-10-14,21,0
2024-10-14,22,0
2024-10-14,23,0
2024-10-15,0,0
2024-10-15,1,0
2024-10-15,2,0
2024-10-15,3,0
2024-10-15,4,0
2024-10-15,5,0
2024-10-15,6,0
2024-10-15,7,0
2024-10-15,8,0
2024-10-15,9,0
2024-10-15,10,0
2024-10-15,11,0
2024-10-15,12,0
2024-10-15,13,0
2024-10-15,14,0
2024-10-15,15,0
2024-10-15,16,0
2024-10-15,17,0
2024-10-15,18,0
2024-10-15,19,0
2024-10-15,20,0
2024-10-15,21,0
2024-10-15,22,0
2024-10-15,23,0
2024-10-16,0,0
2024-10-16,1,0
2024-10-16,2,0
2024-10-16,3,0
2024-10-16,4,0
2024-10-16,5,0
2024-10-16,6,0
2024-10-16,7,0
2024-10-16,8,0
2024-10-16,9,0
2024-10-16,10,0
2024-10-16,11,0
2024-10-16,12,0
2024-10-16,13,0
2024-10-16,14,0
2024-10-16,15,0
2024-10-16,16,0
2024-10-16,17,0
2024-10-16,18,0
2024-10-16,19,0
2024-10-16,20,0
2024-10-16,21,0
2024-10-16,22,0
2024-10-16,23,0
2024-10-17,0,0
2024-10-17,1,0
2024-10-17,2,0
2024-10-17,3,0
2024-10-17,4,0
2024-10-17,5,0
2024-10-17,6,0
2024-10-17,7,0
2024-10-17,8,0
2024-10-17,9,0
2024-10-17,10,0
2024-10-17,11,0
2024-10-17,12,0
2024-10-17,13,0
2024-10-17,14,0
2024-10-17,15,0
2024-10-17,16,0
2024-10-17,17,0
2024-10-17,18,0
2024-10-17,19,0
2024-10-17,20,0
2024-10-17,21,0
2024-10-17,22,0
2024-10-17,23,0
2024-10-18,0,0
2024-10-18,1,0
2024-10-18,2,0
2024-10-18,3,0
2024-10-18,4,0
2024-10-18,5,0
2024-10-18,6,0
2024-10-18,7,0
2024-10-18,8,0
2024-10-18,9,0
2024-10-18,10,0
2024-10-18,11,0
2024-10-18,12,0
2024-10-18,13,0
2024-10-18,14,0
2024-10-18,15,0
2024-10-18,16,0
2024-10-18,17,0
2024-10-18,18,0
2024-10-18,19,0
2024-10-18,20,0
2024-10-18,21,0
2024-10-18,22,0
2024-10-18,23,0
2024-10-19,0,0
2024-10-19,1,0
2024-10-19,2,0
2024-10-19,3,0
2024-10-19,4,0
2024-10-19,5,0
2024-10-19,6,0
2024-10-19,7,0
2024-10-19,8,0
2024-10-19,9,0
2024-10-19,10,0
2024-10-19,11,0
2024-10-19,12,0
2024-10-19,13,0
2024-10-19,14,0
2024-10-19,15,0
2024-10-19,16,0
2024-10-19,17,0
2024-10-19,18,0
2024-10-19,19,0
2024-10-19,20,0
2024-10-19,21,0
2024-10-19,22,0
2024-10-19,23,0
2024-10-20,0,0
2024-10-20,1,0
2024-10-20,2,0
2024-10-20,3,0
2024-10-20,4,0
2024-10-20,5,0
2024-10-20,6,0
2024-10-20,7,0
2024-10-20,8,0
2024-10-20,9,0
2024-10-20,10,0
2024-10-20,11,0
2024-10-20,12,0
2024-10-20,13,0
2024-10-20,14,0
2024-10-20,15,0
2024-10-20,16,0
2024-10-20,17,0
2024-10-20,18,0
2024-10-20,19,0
2024-10-20,20,0
2024-10-20,21,0
2024-10-20,22,0
2024-10-20,23,0
2024-10-21,0,0
2024-10-21,1,0
2024-10-21,2,0
2024-10-21,3,0
2024-10-21,4,0
2024-10-21,5,0
2024-10-21,6,0
2024-10-21,7,0
2024-10-21,8,0
2024-10-21,9,0
2024-10-21,10,0
2024-10-21,11,0
2024-10-21,12,0
2024-10-21,13,0
2024-10-21,14,0
2024-10-21,15,0
2024-10-21,16,0
2024-10-21,17,0
2024-10-21,18,0
2024-10-21,19,0
2024-10-21,20,0
2024-10-21,21,0
2024-10-21,22,0
2024-10-21,23,0
2024-10-22,0,0
2024-10-22,1,0
2024-10-22,2,0
2024-10-22,3,0
2024-10-22,4,0
2024-10-22,5,0
2024-10-22,6,0
2024-10-22,7,0
2024-10-22,8,0
2024-10-22,9,0
2024-10-22,10,0
2024-10-22,11,0
2024-10-22,12,0
2024-10-22,13,0
2024-10-22,14,0
2024-10-22,15,0
2024-10-22,16,0
2024-10-22,17,0
2024-10-22,18,0
2024-10-22,19,0
2024-10-22,20,0
2024-10-22,21,0
2024-10-22,22,0
2024-10-22,23,0
2024-10-23,0,0
2024-10-23,1,0
2024-10-23,2,0
2024-10-23,3,0
2024-10-23,4,0
2024-10-23,5,0
2024-10-23,6,0
2024-10-23,7,0
2024-10-23,8,0
2024-10-23,9,0
2024-10-23,10,0
2024-10-23,11,0
2024-10-23,12,0
2024-10-23,13,0
2024-10-23,14,0
2024-10-23,15,0
2024-10-23,16,0
2024-10-23,17,0
2024-10-23,18,0
2024-10-23,19,0
2024-10-23,20,0
2024-10-23,21,0
2024-10-23,22,0
2024-10-23,23,0
2024-10-24,0,0
2024-10-24,1,0
2024-10-24,2,0
2024-10-24,3,0
2024-10-24,4,0
2024-10-24,5,0
2024-10-24,6,0
2024-10-24,7,0
2024-10-24,8,0
2024-10-24,9,0
2024-10-24,10,0
2024-10-24,11,0
2024-10-24,12,0
2024-10-24,13,0
2024-10-24,14,0
2024-10-24,15,0
2024-10-24,16,0
2024-10-24,17,0
2024-10-24,18,0
2024-10-24,19,0
2024-10-24,20,0
2024-10-24,21,0
2024-10-24,22,0
2024-10-24,23,0
2024-10-25,0,0
2024-10-25,1,0
2024-10-25,2,0
2024-10-25,3,0
2024-10-25,4,0
2024-10-25,5,0
2024-10-25,6,0
2024-10-25,7,0
2024-10-25,8,0
2024-10-25,9,0
2024-10-25,10,0
2024-10-25,11,0
2024-10-25,12,0
2024-10-25,13,0
2024-10-25,14,0
2024-10-25,15,0
2024-10-25,16,0
2024-10-25,17,0
2024-10-25,18,0
2024-10-25,19,0
2024-10-25,20,0
2024-10-25,21,0
2024-10-25,22,0
2024-10-25,23,0
2024-10-26,0,0
2024-10-26,1,0
2024-10-26,2,0
2024-10-26,3,0
2024-10-26,4,0
2024-10-26,5,0
2024-10-26,6,0
2024-10-26,7,0
2024-10-26,8,0
2024-10-26,9,0
2024-10-26,10,0
2024-10-26,11,0
2024-10-26,12,0
2024-10-26,13,0
2024-10-26,14,0
2024-10-26,15,0
2024-10-26,16,0
2024-10-26,17,0
2024-10-26,18,0
2024-10-26,19,0
2024-10-26,20,0
2024-10-26,21,0
2024-10-26,22,0
2024-10-26,23,0
2024-10-27,0,0
2024-10-27,1,0
2024-10-27,2,0
2024-10-27,3,0
2024-10-27,4,0
2024-10-27,5,0
2024-10-27,6,0
2024-10-27,7,0
2024-10-27,8,0
2024-10-27,9,0
2024-10-27,10,0
2024-10-27,11,0
2024-10-27,12,0
2024-10-27,13,0
2024-10-27,14,0
2024-10-27,15,0
2024-10-27,16,0
2024-10-27,17,0
2024-10-27,18,0
2024-10-27,19,0
2024-10-27,20,0
2024-10-27,21,0
2024-10-27,22,0
2024-10-27,23,0
2024-10-28,0,0
2024-10-28,1,0
2024-10-28,2,0
2024-10-28,3,0
2024-10-28,4,0
2024-10-28,5,0
2024-10-28,6,0
2024-10-28,7,0
2024-10-28,8,0
2024-10-28,9,0
2024-10-28,10,0
2024-10-28,11,0
2024-10-28,12,0
2024-10-28,13,0
2024-10-28,14,0
2024-10-28,15,0
2024-10-28,16,0
2024-10-28,17,0
2024-10-28,18,0
2024-10-28,19,0
2024-10-28,20,0
2024-10-28,21,0
2024-10-28,22,0
2024-10-28,23,0
2024-10-29,0,0
2024-10-29,1,0
2024-10-29,2,0
2024-10-29,3,0
2024-10-29,4,0
2024-10-29,5,0
2024-10-29,6,0
2024-10-29,7,0
2024-10-29,8,0
2024-10-29,9,0
2024-10-29,10,0
2024-10-29,11,0